RLBP1
protein-codingretinaldehyde binding protein 1
Gene summary
The protein encoded by this gene is a 36-kD water-soluble protein which carries 11-cis-retinaldehyde or 11-cis-retinal as physiologic ligands. It may be a functional component of the visual cycle. Mutations of this gene have been associated with severe rod-cone dystrophy, Bothnia dystrophy (nonsyndromic autosomal recessive retinitis pigmentosa) and retinitis punctata albescens. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~11.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0019200
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0011839
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0018877
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0100444
Submitter: ClinGen
RLBP1 has been reported in the literature in association with multiple retinopathy conditions including Retinitis punctata albescens (RPA), Fundus albipunctatus (FA), Bothnia retinal dystrophy, and Newfoundland rod-cone dystrophy (PMIDs: 14718298, 25429852, 10102298, 11868161). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference/ in molecular mechanism, inheritance pattern, or phenotypic variability. Therefore, the disease entities have been lumped under RLBP1-related retinopathy. At least 8 unique variants (missense, nonsense, frameshift etc.) have been reported in probands. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. This gene-disease relationship is also supported by animal models and expression studies. In summary, RLBP1 is definitively associated with autosomal recessive RLBP1-related retinopathy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Retina Expert Panel on 6/3/2021 (SOP Version 8).
Inheritance Pattern: AR
Disease ID:MONDO:0011838
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0007639
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0007639
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0011838
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0011839
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0011838
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0100444
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to RLBP1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000326.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 4 | 111 | 116 | ||
| missense | 4 | 8 | 134 | 12 | 158 | |
| nonsense | 10 | 6 | 2 | 18 | ||
| start loss | 1 | 1 | ||||
| frameshift | 10 | 6 | 1 | 17 | ||
| splice donor/acceptor (+/-2bp) | 4 | 8 | 1 | 13 | ||
| Total | 29 | 29 | 142 | 123 | 0 | 323 |
Highest pathogenic variant AF is 0.00008427492
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000317.1 | 7 | MANE Select | |
| Ensembl | ENSP00000268125.5 | 7 | MANE Select | |
| Ensembl | ENSP00000454740.1 | 3 | Standard | |
| Ensembl | ENSP00000457251.1 | 4 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| rlbp1b | Danio rerio | Structure: pigmentation Quality: decreased intensity abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Vitamin A and Carotenoid Metabolism
- Signaling by GPCR
- Signal Transduction
- The canonical retinoid cycle in rods (twilight vision)
- The retinoid cycle in cones (daylight vision)
Biological Process
- retinoid metabolic process
- vitamin A metabolic process
- visual perception
- response to stimulus
Molecular Function
- 11-cis retinal binding
- retinol binding
Cellular Component
- cellular_component
- cytosol
- cell body
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000268125
- Coding exons
- 7
- Length
- 11883
- Individuals with no LoFs
- 125701
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 47
- Defined
- 125748
- p
- 0.000187
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.308 | 195 | 183 | 1.06 | 0.0000121 | 2081 |
| Missense (PolyPhen) | 79 | 78.134 | 1.0111 | 821 | ||
| Synonymous | 0.326 | 70 | 73.6 | 0.952 | 0.00000487 | 596 |
| Loss of Function | 1.33 | 10 | 15.7 | 0.637 | 8.55e-7 | 171 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00014 | 0.00012 | rare |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.0014 | 0.0014 | notable |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.000097 | 0.000097 | rare |
| South Asian | 0.00013 | 0.00013 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Soluble retinoid carrier essential the proper function of both rod and cone photoreceptors. Participates in the regeneration of active 11-cis-retinol and 11-cis-retinaldehyde, from the inactive 11-trans products of the rhodopsin photocycle and in the de novo synthesis of these retinoids from 11-trans metabolic precursors. The cycling of retinoids between photoreceptor and adjacent pigment epithelium cells is known as the 'visual cycle'. {ECO:0000269|PubMed:19846785}.;
- Disease
- DISEASE: Rod-cone dystrophy Newfoundland (NFRCD) [MIM:607476]: A rod-cone dystrophy reminiscent of retinitis punctata albescens but with a substantially lower age at onset and more-rapid and distinctive progression. Rod-cone dystrophies results from initial loss of rod photoreceptors, later followed by cone photoreceptors loss. {ECO:0000269|PubMed:11868161}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Retinitis punctata albescens (RPA) [MIM:136880]: A form of fleck retina disease characterized by aggregation of white flecks posteriorly in the retina, causing night blindness and delayed dark adaptation. It differs from fundus albipunctatus in being progressive and evolving to generalized atrophy of the retina. {ECO:0000269|PubMed:10102299, ECO:0000269|PubMed:11453974, ECO:0000269|PubMed:9326942}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.216
Intolerance Scores
- LoFtool
- 0.332
- RVIS EVS
- 0.17
- RVIS percentile EVS
- 65.96
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.502
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |